Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Liabilities and Shareholders Equity (2022 - 2023)

Historic Liabilities and Shareholders Equity for Bluejay Diagnostics (BJDX) over the last 2 years, with Q3 2023 value amounting to $8.2 million.

  • Bluejay Diagnostics' Liabilities and Shareholders Equity fell 4749.29% to $8.2 million in Q3 2023 from the same period last year, while for Dec 2023 it was $27.6 million, marking a year-over-year decrease of 5901.55%. This contributed to the annual value of $13.5 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Bluejay Diagnostics reported Liabilities and Shareholders Equity of $8.2 million as of Q3 2023, which was down 4749.29% from $8.5 million recorded in Q2 2023.
  • Bluejay Diagnostics' Liabilities and Shareholders Equity's 5-year high stood at $20.1 million during Q1 2022, with a 5-year trough of $8.2 million in Q3 2023.